The landscape of TIGIT target and clinical application in diseases-Reference-Cited by-同舟云学术

The landscape of TIGIT target and clinical application in diseases

Published:2022-09 Issue:2 Volume:1 Page:
ISSN:2769-6448
Container-title:MedComm – Oncology
language:en
Short-container-title:MedComm – Oncology

Author:

Rui Shu¹²,Kong Xiangyu¹²,Liu Jiaye¹,Wang Liying¹,Wang Xiaofei¹,Zou Xiuhe¹,Zheng Xun¹,Ye Feng³,Xu Heng⁴,Li Zhihui¹,Luo Han¹^ORCID

Affiliation:

1. Division of Thyroid and Parathyroid Surgery, Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease‐Related Molecular Network, Department of General Surgery, West China Hospital Sichuan University Chengdu China

2. West China School of Medicine Sichuan University Chengdu China

3. Key Laboratory of Transplant Engineering and Immunology NHC, West China Hospital, Insititute of Clinical Pathology Sichuan University Chengdu China

4. State Key Laboratory of Biotherapy, West China Hospital Sichuan University Chengdu China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mog2.18

Reference129 articles.

1. Immunosuppressive Strategies that are Mediated by Tumor Cells

2. Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells

3. Immune checkpoints in central nervous system autoimmunity

4. T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice;Cancers;2024-05-10

2. TIGIT: A potential immunotherapy target for gynecological cancers;Pathology - Research and Practice;2024-03